hormoneInjectableControlledSchedule III (US, Anabolic Steroids Control Act)Not FDA-approvedPrescription only (US)The Sustanon brand itself is not FDA-approved or marketed in the US; it is a licensed product in the UK, EU and other marketsUS patients seeking testosterone-ester injections are prescribed single-ester products (e.g., testosterone cypionate or enanthate) rather than the Sustanon blend
Testosterone SustanonBenefits, Dosage & Interactions
Also known as: Sustanon 250
Testosterone Sustanon, also known commonly by its brand name Sustanon 250, is an injectable oil-based formulation of testosterone. It is a blend of four different testosterone esters: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate. Research on Testosterone Sustanon focuses on testosterone support, muscle and strength, and libido.
How much Testosterone Sustanon do people take?
The randomized mixed-ester trial dosed hypogonadal men with intramuscular testosterone-ester injections and titrated on trough testosterone levels rather than a single fixed dose. Route reported: Intramuscular injection in the cited mixed-ester studies. Frequency reported: Every 2–4 weeks, reflecting the blended short- and long-acting esters in the formulation. These are amounts documented in the cited studies and labels for Testosterone Sustanon — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
See the full reported protocol and its sourcesResearched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Evidence: Moderate — One published human randomized trial; results not yet replicated.
Evidence strengthModerate · 3/4
PreclinicalStrong human evidence
One published human randomized trial; results not yet replicated.
Plasma half-life
Reported to combine a short-acting propionate component with longer phenylpropionate, isocaproate and decanoate esters, giving an initial rapid rise followed by a sustained release over weeks
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The randomized mixed-ester trial dosed hypogonadal men with intramuscular testosterone-ester injections and titrated on trough testosterone levels rather than a single fixed dose[1]
- Route studied
- Intramuscular injection in the cited mixed-ester studies[1]
- Frequency
- Every 2–4 weeks, reflecting the blended short- and long-acting esters in the formulation[1]
- Half-life
- Reported to combine a short-acting propionate component with longer phenylpropionate, isocaproate and decanoate esters, giving an initial rapid rise followed by a sustained release over weeks[1]
Reported for Testosterone Sustanon in the cited sources. Published ranges are not dosing advice.
Mixing Testosterone Sustanon: bacteriostatic water and syringe units
The vial arrives as dry powder. How much water you add sets the strength, and the strength sets the mark you draw to on the syringe. The table assumes a 5 mg vial and a 250 mcg example draw on a U-100 insulin syringe, where 100 units is one millilitre. If your vial is a different size, scale it — the arithmetic is the same.
| Bacteriostatic water added | Resulting strength | 250 mcg draws to |
|---|---|---|
| 1 mL | 5 mg/mL | 5 units |
| 2 mL | 2.5 mg/mL | 10 units |
| 3 mL | 1.67 mg/mL | 15 units |
Units, not millilitres. Insulin syringes are marked in units, and mixing up mcg and mg on a peptide label is the single most common error people report. Check the label twice. Run your own vial through the calculator.
Storage and stability
- Before mixing
- Sealed and still as a dry powder, Testosterone Sustanon vials are normally kept in the fridge at 2–8 °C, out of light. Short spells at room temperature during shipping are the norm for lyophilized peptides and are not, on their own, a sign the vial is spoiled.
- After mixing
- Once bacteriostatic water goes in, the vial belongs in the fridge and is generally treated as good for about 28 days — that is how long the benzyl alcohol in bacteriostatic water is relied on to hold back bacterial growth. Plain sterile water has no preservative, so a vial mixed with it is a single-session vial. Never freeze a reconstituted vial.
- When to throw it out
- A properly mixed vial is clear. Cloudiness, floating strands, a color change or powder that will not go into solution after gentle swirling all mean the vial should be discarded rather than used. Shaking a peptide vial hard is the usual cause — swirl it, or run the water down the inside wall of the vial instead of onto the powder.
Handling and shelf-life figures describe general practice for lyophilized peptides. They are not a dose and not medical advice — your prescriber or the product label sets the amount.
References & evidence
Documents the Testosterone Sustanon entry is written from. Each number matches an inline marker above.
- [1]Randomized clinical trial of testosterone replacement therapy in hypogonadal menConway AJ, Boylan LM, Howe C, Ross G, Handelsman DJ · International Journal of Andrology · 1988 · Peer-reviewed · PMID 3139571
- [2]Bioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal menNieschlag E, Mauss J, Coert A, Kicovic P · Hormone Research · 1976 · Peer-reviewed · PMID 1002121
- [3]Injectable testosterone undecanoate has more favourable pharmacokinetics and pharmacodynamics than testosterone enanthatePartsch CJ, Weinbauer GF, Fang R, Nieschlag E · European Journal of Endocrinology · 1995 · Peer-reviewed · PMID 7711892
References & Evidence
Sources on this page that document Testosterone Sustanon dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Testosterone Sustanon studied for?
What is Testosterone Sustanon?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Testosterone Sustanon, also known commonly by its brand name Sustanon 250, is an injectable oil-based formulation of testosterone. It is a blend of four different testosterone esters: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate. The combination of these esters is designed to provide both a rapid onset of action and a prolonged release of testosterone into the bloodstream. This sustained release aims to maintain more stable blood testosterone levels over time, compared to single-ester formulations that might require more frequent injections. Sustanon is primarily used in hormone replacement therapy (HRT) for men with insufficient natural testosterone production (hypogonadism). It is also used in some contexts for its anabolic effects, such as increasing muscle mass and strength, though this use is often off-label or within medically supervised protocols in specific conditions. As a controlled substance, its use is regulated globally due to its potential for misuse and abuse.
What does the research say about Testosterone Sustanon?
Tap a section to expand.
Testosterone Sustanon delivers testosterone, a primary androgenic hormone, into the body. Once injected, the ester chains (propionate, phenylpropionate, isocaproate, decanoate) are slowly cleaved by esterase enzymes in the bloodstream, releasing free testosterone. Each ester has a different half-life, contributing to the blend's characteristic pharmacokinetic profile. Testosterone then binds to androgen receptors located in various tissues throughout the body, including muscle, bone, and adipose tissue. This binding initiates a cascade of intracellular events that lead to specific biological responses. In muscle tissue, testosterone promotes protein synthesis and nitrogen retention, leading to muscle growth (anabolism). It also affects bone mineral density, red blood cell production (via erythropoiesis stimulation in the kidneys), and maintains secondary sexual characteristics. Additionally, testosterone can be converted to dihydrotestosterone (DHT) by the 5-alpha-reductase enzyme in some tissues, which is a more potent androgen, and to estradiol by the aromatase enzyme, which is an estrogen. These metabolites also mediate some of testosterone's effects, influencing various physiological processes including libido, mood, and bone health.
Source for this section: Sources for How does Testosterone Sustanon work?: Jumps to this entry in the sources and references list at the end of the page.
The primary medical benefit of Testosterone Sustanon is the treatment of male hypogonadism, a condition characterized by insufficient testosterone production. In hypogonadal men, testosterone replacement therapy can alleviate symptoms suchoreduced libido, erectile dysfunction, fatigue, depressed mood, decreased muscle mass, and lowered bone mineral density. Clinical studies cited by groups like the Endocrine Society and Mayo Clinic indicate that restoring testosterone to physiological levels can improve these symptoms, enhance energy levels, promote lean body mass, and increase bone density. By maintaining more stable testosterone levels compared to some other formulations, Sustanon may help to reduce fluctuations in mood and energy. In contexts where it is used for anabolic purposes, such as in specific medical conditions like wasting syndromes, its ability to increase protein synthesis and nitrogen retention can lead to gains in muscle mass and strength. However, these anabolic effects in otherwise healthy individuals are often associated with non-medical use and significant health risks. For medically-indicated purposes, the goal is to restore normal physiological function rather than supra-physiological enhancement.
Evidence supporting the efficacy of testosterone replacement therapy, including formulations like Sustanon, for male hypogonadism is well-established in the medical literature. Organizations such as the American Urological Association (AUA) and the Endocrine Society have published clinical practice guidelines based on extensive research. Studies have demonstrated that testosterone replacement can improve sexual function, mood, energy levels, and body composition in men with clinically diagnosed hypogonadism. For instance, a review by the NIH Office of Disease Supplements (ODS) and various meta-analyses in journals like *The Lancet Diabetes & Endocrinology* consistently show positive effects on these parameters when testosterone levels are restored to the normal range. The extended release profile of Sustanon, due to its blend of esters, has been characterized in pharmacokinetic studies, indicating its ability to maintain stable testosterone concentrations over several weeks, which can reduce injection frequency compared to shorter-acting single esters. However, head-to-head comparisons demonstrating superior clinical outcomes over other long-acting testosterone esters are less conclusive, with much of the benefit attributed to testosterone itself rather than the specific ester blend. The use of Testosterone Sustanon for bodybuilding or performance enhancement in individuals without a medical need for testosterone replacement is not supported by medical organizations and carries significant health risks.
Common side effects associated with Testosterone Sustanon, similar to other testosterone preparations, can include acne, oily skin, hair loss (androgenic alopecia), and gynecomastia (breast enlargement in men) due to conversion of testosterone to estrogen. Other potential side effects include mood swings, increased aggression, fluid retention, and alterations in lipid profiles. Elevated red blood cell count (polycythemia) is a known concern, which can increase the risk of blood clots. Liver enzyme elevations, although less common with injectable testosterone than with oral formulations, can occur. Pain or irritation at the injection site is also possible. More serious, though less frequent, side effects can include sleep apnea exacerbation and potential cardiovascular events, particularly in individuals with pre-existing risk factors. Long-term use without medical supervision can lead to testicular atrophy and impaired spermatogenesis, resulting in infertility. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Testosterone Sustanon should be used with extreme caution in individuals with pre-existing cardiovascular disease, prostate cancer, or breast cancer. It is contraindicated in men with known or suspected prostate or breast cancer due to concerns that testosterone may stimulate tumor growth. Individuals with severe cardiac, renal, or hepatic insufficiency should use testosterone replacement with extreme caution as fluid retention and edema, sometimes with congestive heart failure, may be aggravated. Patients with sleep apnea should be carefully monitored as testosterone therapy can exacerbate the condition. Women and children should not use this product due to its potent androgenic effects. Regular monitoring of testosterone levels, hemoglobin and hematocrit, lipid profiles, and prostate-specific antigen (PSA) levels is crucial during therapy to manage potential side effects and ensure therapeutic efficacy. Any unexplained pain, shortness of breath, sudden vision changes, or signs of a clot (e.g., pain or swelling in a limb) should be reported to a clinician immediately. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Testosterone Sustanon is strictly contraindicated in specific populations and conditions. These include known or suspected prostate carcinoma or breast carcinoma in males, as testosterone can stimulate the growth of these hormone-sensitive cancers. It is also contraindicated in women, especially during pregnancy and breastfeeding, due to the risk of virilization of the fetus and infant. Individuals with hypercalcemia associated with malignancy are also contraindicated. Severe cardiac, renal, or hepatic insufficiency can also be a contraindication, particularly if accompanied by edema or congestive heart failure. Personal history of deep vein thrombosis or pulmonary embolism may also be considered a contraindication. Individuals with hypersensitivity to any component of the formulation are also contraindicated. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Testosterone Sustanon can interact with several medications and substances. Concurrent use with oral anticoagulants, such as warfarin, may potentiate their effects, increasing the risk of bleeding. Close monitoring of coagulation parameters is essential. Insulin and other antidiabetic agents may have their effects altered, requiring dose adjustments of antidiabetic medications. Corticosteroids may increase the risk of fluid retention and edema when co-administered. Thyroid hormones should also be monitored as testosterone can decrease levels of thyroid-binding globulin, potentially leading to increased free thyroid hormone levels. Diuretics may be needed to manage fluid retention. Drug-drug interactions can be complex and impact both the efficacy and safety of Testosterone Sustanon and co-administered medications. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Testosterone Sustanon is administered via intramuscular injection. Due to its blend of esters providing varying release rates, the typical injection frequency is less frequent than single, short-acting testosterone esters. Depending on individual patient response and clinician's discretion, injections are commonly spaced every 2 to 4 weeks. The goal of this regimen is to maintain stable physiological testosterone levels without significant peaks and troughs. The specific timing of injection (e.g., morning or evening) within the chosen frequency does not significantly impact overall efficacy, as the release is sustained over a prolonged period. However, consistency in the injection schedule is generally recommended by clinicians to ensure steady hormone levels.
Source for this section: Sources for When should you take Testosterone Sustanon?: Jumps to this entry in the sources and references list at the end of the page.
Put it into practice
Reading about Testosterone Sustanon is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with Testosterone Sustanon?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about Testosterone Sustanon
Sustanon is a blend of four different testosterone esters (propionate, phenylpropionate, isocaproate, and decanoate), designed to provide both a rapid initial release and a prolonged, sustained release of testosterone. Other formulations may contain a single ester (e.g., testosterone enanthate, cypionate) which typically have different durations of action and injection frequencies.
Testosterone Sustanon is a controlled substance in many countries, including the United States. It is legal only when prescribed by a licensed medical professional for legitimate medical conditions, such as hypogonadism.
Patients may begin to notice improvements in symptoms like energy levels and mood within a few weeks, while effects on muscle mass and bone density may take several months to become evident. Sexual function improvements can also vary, with initial changes often reported after several weeks of consistent treatment.
No, Sustanon is not indicated for use in women. It is a powerful androgen and can cause irreversible virilizing effects such as deepening of the voice, increased body hair, and clitoral enlargement. It is contraindicated in women, especially during pregnancy and breastfeeding.
Interaction risk for Testosterone Sustanon comes from the rest of the stack: other hormones, prescription medicines, hormone therapy and peptides. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Testosterone Sustanon with no sign-up.
Testosterone Sustanon is administered by injection, so the measured volume — not a tablet count — is the unit that matters. It is a controlled substance in some jurisdictions, so the prescribed amount is the only appropriate one. Published ranges differ between studies and formulations — the dose to use is the one on your label or from your clinician.
There is no single answer for Testosterone Sustanon plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Testosterone Sustanon with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Testosterone Sustanon varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Testosterone Sustanon depends on the protocol and formulation you are on. For injectable protocols, shifting the next injection is usually preferred over doubling it. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For an injectable like Testosterone Sustanon the record needs more than a checkbox: vial concentration, the measured volume, and which site the last injection went into. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
The randomized mixed-ester trial dosed hypogonadal men with intramuscular testosterone-ester injections and titrated on trough testosterone levels rather than a single fixed dose. Route reported: Intramuscular injection in the cited mixed-ester studies. Frequency reported: Every 2–4 weeks, reflecting the blended short- and long-acting esters in the formulation. These are amounts documented in the cited studies and labels for Testosterone Sustanon — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
Which studies looked at Testosterone Sustanon?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option(opens PubMed in a new tab)The Journal of clinical endocrinology and metabolism · 2022 · PMID 34698352 · https://pubmed.ncbi.nlm.nih.gov/34698352/
- 2.Drug insight: testosterone preparations(opens PubMed in a new tab)Nature clinical practice. Urology · 2006 · PMID 17149382 · https://pubmed.ncbi.nlm.nih.gov/17149382/
- 3.Testosterone replacement therapy: current trends and future directions(opens PubMed in a new tab)Human reproduction update · 2004 · PMID 15297434 · https://pubmed.ncbi.nlm.nih.gov/15297434/
- 4.Safety and efficacy of testosterone gel in the treatment of male hypogonadism(opens PubMed in a new tab)Clinical interventions in aging · 2009 · PMID 19966909 · https://pubmed.ncbi.nlm.nih.gov/19966909/
- 5.Testosterone treatment in elderly men(opens PubMed in a new tab)Advances in therapy · 2009 · PMID 19198768 · https://pubmed.ncbi.nlm.nih.gov/19198768/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 155142(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/155142
Verify at
Publisher search links for Testosterone Sustanon. These are places to check the information — they are not citations, so they are not numbered.
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Clinical practice guidelines (PubMed)(publisher search, opens in a new tab)National Library of Medicine · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Testosterone Sustanon?
Plain-text summary, safe to quote verbatim:
Testosterone Sustanon, also known commonly by its brand name Sustanon 250, is an injectable oil-based formulation of testosterone. It is a blend of four different testosterone esters: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate. Research on Testosterone Sustanon focuses on testosterone support, muscle and strength, and libido.
Source: DoseRoutine — https://doseroutine.com/library/testosterone-sustanon
Testosterone Sustanon cheat sheet
DoseRoutine cheat sheet · Hormone
Testosterone Sustanon
Testosterone Sustanon, also known commonly by its brand name Sustanon 250, is an injectable oil-based formulation of testosterone. It is a blend of four different testosterone esters: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate.
Evidence
Moderate
One published human randomized trial; results not yet replicated.
Studied range
The randomized mixed-ester trial dosed hypogonadal men with intramuscular testosterone-ester injections and titrated on trough testosterone levels rather than a single fixed dose
Route
Intramuscular injection in the cited mixed-ester studies
Frequency studied
Every 2–4 weeks, reflecting the blended short- and long-acting esters in the formulation
Half-life
Reported to combine a short-acting propionate component with longer phenylpropionate, isocaproate and decanoate esters, giving an initial rapid rise followed by a sustained release over weeks
Schedule III (US, Anabolic Steroids Control Act)Not FDA-approvedPrescription only (US)The Sustanon brand itself is not FDA-approved or marketed in the US; it is a licensed product in the UK, EU and other marketsUS patients seeking testosterone-ester injections are prescribed single-ester products (e.g., testosterone cypionate or enanthate) rather than the Sustanon blendTestosteroneMuscleLibido
Key references
- Randomized clinical trial of testosterone replacement therapy in hypogonadal men (1988)
- Bioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal men (1976)
- Injectable testosterone undecanoate has more favourable pharmacokinetics and pharmacodynamics than testosterone enanthate (1995)
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/testosterone-sustanon
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Testosterone Sustanon — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/testosterone-sustanon
What compounds are similar to Testosterone Sustanon?
Others in the hormone category or studied for the same goals.
Which goals is Testosterone Sustanon used for?
Other compounds studied for the same benefits as Testosterone Sustanon.
Continue exploring
See every compound DoseRoutine catalogs for these goals.